UK government accepts all 44 healthcare AI regulation recommendations

The government accepted all 44 recommendations published by the Commission on 10 September 2026 and said it had set out how they would be delivered across the UK.[1][2] A full implementation roadmap, with timelines and responsibilities for every recommendation, is due by Spring 2027, followed by regular progress updates.[1] That means the acceptance is a policy commitment, while the detailed schedule is still to come. For teams planning governance or product work, the roadmap should be a key point to check: the government has not yet provided the complete set of delivery timelines and assigned responsibilities in the evidence available here.[1]

The Commission said healthcare AI regulation should evolve toward a more proportionate, lifecycle-based framework.[1] It recommended assessing and monitoring AI-enabled medical devices throughout their working life, rather than relying heavily on one-time assessments.[1] The government said the MHRA would issue draft guidance by December 2026 on managing changes as these devices adapt and improve; the agency will begin consulting in 2027 on how to qualify and classify them.[1] These are planned steps, not final guidance or completed changes to the rules. The government also said current medical-device regulations were not fit for purpose.[4]

The MHRA opened applications for the third phase of AI Airlock on 6 October 2026.[1] The regulatory sandbox will focus on post-market surveillance and lifecycle regulation, testing how AI devices can be monitored and managed safely after deployment; the MHRA says evidence from the phase will inform future guidance and policy.[1] Organisations of any size may apply, and a lead applicant may partner with others.[3] There is no application or participation fee, but applicants are expected to fund their own studies and testing.[3] AI Airlock has three years of additional government funding after its pilot and Phase 2 programme, and the current phase is funded until April 2029.[1][3]

More than 12,000 patients, clinicians and members of the public shaped the Commission’s recommendations.[1] The government committed to improving patient engagement, access to redress when care falls below expectations, and fair distribution of AI benefits, including to underserved groups.[1] It also said patients would be kept informed about when AI is used in their care.[1] The Commission was established by the MHRA in September 2025 as an independent, non-statutory advisory body.[1] Scotland said it would continue working with UK partners and set out its response in due course.[1]